Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 6 , Pages 496-502 , November 2006

E-cadherin promoter polymorphisms are not associated with the aggressiveness of prostate cancer in Caucasian patients

  • He-Cheng Li, M.D., Ph.D.

      Affiliations

    • Vanderbilt University School of Medicine, Nashville, TN 37232, USA
    • ,
  • Jeffrey M. Albert, B.S.

      Affiliations

    • Department of Radiation Oncology and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
    • ,
  • Eric T. Shinohara, M.D.

      Affiliations

    • Department of Radiation Oncology and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
    • ,
  • Qiuyin Cai, M.D., Ph.D.

      Affiliations

    • Department of Medicine and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
    • ,
  • Andrea Freyer, B.S.

      Affiliations

    • Department of Radiation Oncology and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
    • ,
  • Hui Cai, M.D., Ph.D.

      Affiliations

    • Department of Medicine and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
    • ,
  • Carolyn Cao, M.S.

      Affiliations

    • Department of Radiation Oncology and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
    • ,
  • Zuofei Wang, M.D.

      Affiliations

    • Department of Radiation Oncology and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
    • ,
  • Nobuhiko Kataoka, M.D., Ph.D.

      Affiliations

    • Department of Medicine and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
    • ,
  • Ming Teng, M.D.

      Affiliations

    • Department of Radiation Oncology and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
    • ,
  • Wei Zheng, M.D., Ph.D.

      Affiliations

    • Department of Medicine and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
    • ,
  • Bo Lu, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-615-343-9233; fax: +1-615-343-0161.

Received 8 September 2005 ,Revised 8 February 2006 ,Accepted 9 February 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This work was supported by DOD PC031161 to B.L., RO1CA90899 to W.Z., and UICC fellowship ICRETT1025 to H.C.L.

PII: S1078-1439(06)00062-7

doi: 10.1016/j.urolonc.2006.02.018

Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 6 , Pages 496-502 , November 2006

Article Tools

* Image Usage & Resolution